NASDAQ:CLSD   Clearside Biomedical, Inc.
Uptrend Consolidation
SMA200 as support
OBV> OBV34
WR% Crossed -80

Entry 2.47
Stop 2
Target 4.3

Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
交易進行:
BuyToOpen (BTO) 2022 Jan C2.5/5 limit 0.45
Delta 0.4
No Stop in this OP trade;
MAX RRR 4:1
交易結束:目標達成:
closed 1.15, small winner
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。